ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TELO Telomir Pharmaceuticals Inc

6.91
0.37 (5.66%)
May 11 2024 - Closed
Delayed by 15 minutes

Telomir Pharmaceuticals Financial Summary

The current TELO market cap is 204.6M. The company's latest EPS is USD -0.4415 and P/E is -15.63.

Quarter End
USD ($)USD ($)USD ($)
Total Revenue
Operating Income
Net Income
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -138k-854k-3.94M
Net Income -138k-854k-13.07M
Quarter End
USD ($)USD ($)USD ($)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 049k4.77M
Total Liabilities 138k986k1.34M
Total Equity -138k-937k3.44M
Quarter End
USD ($)USD ($)USD ($)
Operating
Investing
Financing
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -119k-469k-3.86M
Investing N/A N/A N/A
Financing 119k470k3.86M
Market Cap 204.6M
Price to Earnings Ratio -15.63
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 59.43
Dividend Yield -

Share Statistics

Shares Outstanding 29.61M
Average Volume (1 week) 34.22k
Average Volume (1 Month) 56.16k
52 Week Change -1.29%
52 Week High 20.72
52 Week Low 4.76
Spread (Intraday) 92.3 (93.23%)

Company Info

Company Name Telomir Pharmaceuticals Inc
Address 900 west platt street, suite 200
tampa, florida 33606
Website https://www.telomirpharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock